Logo

Green Light Biosciences

 http://greenlightbiosciences.com/

STAT: Businesses across the vaccine supply chain must work together to make Covid-19 vaccines

STAT: BUSINESSES ACROSS THE VACCINE SUPPLY CHAIN MUST WORK TOGETHER TO MAKE COVID-19 VACCINES

Andrey Zarur, CEO of GreenLight Biosciences, writes for STAT about the vaccine supply chain and how we need to work together to make...

Financial Times: Get vaccine new variant ready

FINANCIAL TIMES: GET VACCINE NEW VARIANT READY

GreenLight Biosciences explain to the Financial Times how messenger RNA can help get the Covid-19 vaccine new variant ready. GreenLight...

 
 
 
FT: Vaccine makers race to fix vaccine supply issues

FT: VACCINE MAKERS RACE TO FIX VACCINE SUPPLY ISSUES

GreenLight Biosciences explain to the Financial Times the vaccine supply issues for a Covid-19 vaccine. GreenLight Biosciences spoke...

Mail Online: Vaccine roll out issues

MAIL ONLINE: VACCINE ROLL OUT ISSUES

GreenLight Biosciences explain to the Mail Online about the vaccine roll out issues for a Covid-19 vaccine. GreenLight Biosciences...

 
 
 
Technology Review: What are the Pfizer covid-19 vaccine ingredients?

TECHNOLOGY REVIEW: WHAT ARE THE PFIZER COVID-19 VACCINE INGREDIENTS?

GreenLight Biosciences helped explain the vaccine ingredients for a Covid-19 vaccine to Technology Review. Credit: MS TECH | GETTY GreenLight...

Investors Business Daily: Vaccine manufacturing challenge

INVESTORS BUSINESS DAILY: VACCINE MANUFACTURING CHALLENGE

GreenLight CEO, Andrey Zarur, speaks to for Investor's Business daily about the challenge of vaccine manufacturing for Covid-19. Credit:...

 
 
 
Five Question Friday: Archie Mathura

FIVE QUESTION FRIDAY: ARCHIE MATHURA

Meet Archie, December's Question Friday participant! Archie is GreenLight's corporate controller, where she supports the company's...

FT: Vaccine manufacturing delays leave UK with fewer vaccines than hoped

FT: VACCINE MANUFACTURING DELAYS LEAVE UK WITH FEWER VACCINES THAN HOPED

GreenLight CEO, Andrey Zarur, speaks to Financial Times about what's behind the Covid-19 vaccine manufacturing delays for the UK. Credit:...

 
 
 
BioSpace: Harnessing Nature for Faster mRNA Vaccine Manufacturing

BIOSPACE: HARNESSING NATURE FOR FASTER MRNA VACCINE MANUFACTURING

GreenLight CEO, Andrey Zarur, speaks to Biospace about the potential of a messenger RNA vaccine for Covid-19 Andrey Zarur, Ph.D., president...

CNBC: The challenges of Covid-19 vaccine production for the masses

CNBC: THE CHALLENGES OF COVID-19 VACCINE PRODUCTION FOR THE MASSES

CNBC speaks to GreenLight CEO, Andrey Zarur, about the challenge of vaccine production for Covid-19. Credit: Dado Ruvic | Reuters Andrey...

 
 
 
Metro: how Covid vaccine could transform the world

METRO: HOW COVID VACCINE COULD TRANSFORM THE WORLD

GreenLight CEO, Andrey Zarur, talks to Metro about supply issues with the Covid vaccine and how to make RNA. Credit: Metro.co.uk GreenLight...

Daily Mail: Suppliers of vaccine materials do not have capacity

DAILY MAIL: SUPPLIERS OF VACCINE MATERIALS DO NOT HAVE CAPACITY

GreenLight CEO, Andrey Zarur, has been quoted in the Daily Mail about supply chain issues relating to vaccine materials for Covid-19. Credit:...

 
 
 
Unherd: Will a vaccine stop Covid?

UNHERD: WILL A VACCINE STOP COVID?

GreenLight CEO, Andrey Zarur, speaks to Unherd about vaccine production for Covid-19. Credit: Juan Carlos Lucas/NurPhoto/Getty Images GreenLight...

Fortune: If we don't vaccinate the world quickly, all our COVID efforts will be a waste

FORTUNE: IF WE DON'T VACCINATE THE WORLD QUICKLY, ALL OUR COVID EFFORTS WILL BE A WASTE

GreenLight CEO, Andrey Zarur, writes for Fortune about vaccine rollout for Covid-19. Credit: ALEX EDELMAN-GETTY IMAGES GreenLight CEO,...

 
 
 
Investors Business Daily: Vaccine manufacturing challenge

INVESTORS BUSINESS DAILY: VACCINE MANUFACTURING CHALLENGE

GreenLight CEO, Andrey Zarur, speaks to for Investor's Business daily about the challenge of vaccine manufacturing for Covid-19. Credit:...

Fortune: If we don't vaccinate the world quickly, all our COVID efforts will be a waste

FORTUNE: IF WE DON'T VACCINATE THE WORLD QUICKLY, ALL OUR COVID EFFORTS WILL BE A WASTE

GreenLight CEO, Andrey Zarur, writes for Fortune about vaccine rollout for Covid-19. Credit: ALEX EDELMAN-GETTY IMAGES GreenLight CEO,...

 
 
 
WFH Series: Elisha Fielding

WFH SERIES: ELISHA FIELDING

Up next in our work from home series is Elisha Fielding, Ph.D., Senior Scientist, Biochemist at GreenLight. Elisha shares her work...

Daily Mail: Suppliers of vaccine materials do not have capacity

DAILY MAIL: SUPPLIERS OF VACCINE MATERIALS DO NOT HAVE CAPACITY

GreenLight CEO, Andrey Zarur, has been quoted in the Daily Mail about supply chain issues relating to vaccine materials for Covid-19. Credit:...

 
 
 
Unherd: Will a vaccine stop Covid?

UNHERD: WILL A VACCINE STOP COVID?

GreenLight CEO, Andrey Zarur, speaks to Unherd about vaccine production for Covid-19. Credit: Juan Carlos Lucas/NurPhoto/Getty Images GreenLight...

Metro: how Covid vaccine could transform the world

METRO: HOW COVID VACCINE COULD TRANSFORM THE WORLD

GreenLight CEO, Andrey Zarur, talks to Metro about supply issues with the Covid vaccine and how to make RNA. Credit: Metro.co.uk GreenLight...

 
 
 



World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Bond LSC Researchers Named Most Highly Cited for 2020

Bond LSC Researchers Named Most Highly Cited for 2020

Bond Life Sciences Center principal investigators Bing Yang and Ron Mittler are pictured above. | photos by Erica Overfelt, Bond LSC. By Lauren Hines | Bond LSC Building onto... Read more ...

A New Way to Measure Record-Setting Electron Beams

A New Way to Measure Record-Setting Electron Beams

Sam Barber, left, a research scientist at Berkeley Lab's BELLA Center, and Jeroen van Tilborg, a staff scientist at the BELLA Center, hold the active plasma lens, right, and... Read more ...

Researchers Find Cerebrospinal Fluid Boosts Cancer Cell Aggression

Researchers Find Cerebrospinal Fluid Boosts Cancer Cell Aggression

In cell studies, Mayo researchers and collaborators have uncovered why tumor cells from glioblastoma are more aggressive in one part of the brain than in others. In an article... Read more ...

Historical evolution of spheroids and organoids, and possibilities of use in...

Historical evolution of spheroids and organoids, and possibilities of use in life sciences and medicine

Abstract Background An impressive percentage of biomedical advances were achieved through animal research and cell culture investigations. For drug testing and disease... Read more ...

PSC Software™ Announces the Release of Microsoft Office 365 Integration in...

PSC Software™ Announces the Release of Microsoft Office 365 Integration in Adaptive Compliance Engine® Version 3.5.0

Written By: PSC Software Business Development and Marketing Teams PSC Software , a wholly owned subsidiary of PSC Biotech Corporation , is pleased to announce the integration... Read more ...

The Importance of Good Documentation Practices

The Importance of Good Documentation Practices

Written By: Akshaya Mohan, Regulatory Affairs Manager, PSC Biotech® Documentation is a “record” or “evidence” of an event that has happened. In the life-science industry “If it... Read more ...

RNAi-based products: A sustainable alternative to hazardous pesticides

RNAi-based biocontrol is a great alternative to hazardous pesticides and can contribute towards reversing the alarming decline in farmland birds and beneficial insects . Read more ...

Key switchgrass genes identified, which could mean better biofuels ahead

Biologists believe they are one step closer to a long-held goal of making a cheap, widely available plant a source for energy and fuel, meaning one of the next big weapons in... Read more ...

Genome-editing tool TALEN outperforms CRISPR-Cas9 in tightly packed DNA

Researchers used single-molecule imaging to compare the genome-editing tools CRISPR-Cas9 and TALEN. Their experiments revealed that TALEN is up to five times more efficient... Read more ...

Blocking drug efflux mechanisms facilitate genome engineering process in...

Penicillium funiculosum NCIM1228 is a non-model filamentous fungus that produces high-quality secretome for lignocellulosic biomass saccharification. Despite having desirable... Read more ...